Aratana Therapeutics recently announced the appointment of Robert “Rip” Gerber as an Independent Director on Aratana’s Board of Directors. Aratana Therapeutics is a biopharmaceutical company developing innovative medicines for cats and dogs.
Gerber is the founder, President and CEO of Locaid, a developer of “Location-as-a-Service” (LaaS), and built Locaid into world’s largest LaaS platform. He was been a senior executive as several private and public companies. He also helped to orchestrate the restructuring, repositioning and re-branding of Intellisync, a wireless software company. He co-founded Commtouch where he served as Chief Marketing Officer and ultimately helped take the company public in 1999.
“I see Aratana as an industry pioneer, based upon the Company’s expertise and willingness to blaze a new trail in companion animal therapeutics,” Gerber shared. “I am attracted to this business platform because it not only fulfills an important medical need for pets and pet owners, but also represents a tremendous opportunity for the biotech and pharmaceutical community to increase the value of their pipelines.”
Earlier in Gerber’s career, he Gerber founded @once, an email marketing company that was acquired by InfoUSA. His MBA is from Harvard Business School and he has a B.S. in Chemical Engineering from the University of Virginia.
Steven St. Peter, M.D., Chief Executive Officer of Aratana Therapeutics, stated, “We are already benefitting from Rip’s keen entrepreneurial spirit, enthusiasm, and experience as an accomplished executive.”
Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and develops strategies to maximize the value of the programs. For more information, visit www.aratanatherapeutics.com.